| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| STANKEY JOHN T | CEO & President, Director | 208 S. AKARD ST., DALLAS | /s/ Johnell C. Holland, Attorney-in-fact | 04 Nov 2025 | 0001240292 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | T | Common Stock | Award | $20.9K | +844 | +1.12% | $24.75 | 76.1K | 31 Oct 2025 | By Benefit Plan | F1 |
| holding | T | Common Stock | 17K | 31 Oct 2025 | By 401(k) | F2 | |||||
| holding | T | Common Stock | 960K | 31 Oct 2025 | By Family Trust | ||||||
| holding | T | Common Stock | 120K | 31 Oct 2025 | By LP |
| Id | Content |
|---|---|
| F1 | Represents reinvestment of dividend equivalents on deferred stock units purchased by the reporting person. Deferred stock units are settled only in stock on a 1-for-1 basis. |
| F2 | Based on a 401(k) plan statement dated 9/30/2025. |